Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Association of Bariatric Surgery With Skin Cancer Incidence in Adults With Obesity: A Nonrandomized Controlled Trial.

Taube M, Peltonen M, Sjöholm K, Anveden Å, Andersson-Assarsson JC, Jacobson P, Svensson PA, Bergo MO, Carlsson LMS.

JAMA Dermatol. 2019 Oct 30:1-7. doi: 10.1001/jamadermatol.2019.3240. [Epub ahead of print]

PMID:
31664428
2.

Complement Activation Occurs at the Surface of Platelets Activated by Streptococcal M1 Protein and This Results in Phagocytosis of Platelets.

Palm F, Sjöholm K, Malmström J, Shannon O.

J Immunol. 2019 Jan 15;202(2):503-513. doi: 10.4049/jimmunol.1800897. Epub 2018 Dec 12.

PMID:
30541884
3.

Reply: Bariatric surgery and chronic kidney disease: much hope, but proof is still awaited.

Shulman A, Peltonen M, Andersson-Assarsson JC, Sjöholm K, le Roux CW, Svensson PA.

Int J Obes (Lond). 2018 Aug;42(8):1534. doi: 10.1038/s41366-018-0159-1. Epub 2018 Jul 17. No abstract available.

PMID:
30018310
4.

Long-term incidence of serious fall-related injuries after bariatric surgery in Swedish obese subjects.

Carlsson LMS, Sjöholm K, Ahlin S, Jacobson P, Andersson-Assarsson JC, Karlsson Lindahl L, Maglio C, Karlsson C, Hjorth S, Taube M, Carlsson B, Svensson PA, Peltonen M.

Int J Obes (Lond). 2019 Apr;43(4):933-937. doi: 10.1038/s41366-018-0097-y. Epub 2018 May 24.

5.

Associations of Bariatric Surgery With Changes in Interpersonal Relationship Status: Results From 2 Swedish Cohort Studies.

Bruze G, Holmin TE, Peltonen M, Ottosson J, Sjöholm K, Näslund I, Neovius M, Carlsson LMS, Svensson PA.

JAMA Surg. 2018 Jul 1;153(7):654-661. doi: 10.1001/jamasurg.2018.0215.

6.

Incidence of end-stage renal disease following bariatric surgery in the Swedish Obese Subjects Study.

Shulman A, Peltonen M, Sjöström CD, Andersson-Assarsson JC, Taube M, Sjöholm K, le Roux CW, Carlsson LMS, Svensson PA.

Int J Obes (Lond). 2018 Jun;42(5):964-973. doi: 10.1038/s41366-018-0045-x. Epub 2018 Feb 26.

7.

Risk of suicide and non-fatal self-harm after bariatric surgery: results from two matched cohort studies.

Neovius M, Bruze G, Jacobson P, Sjöholm K, Johansson K, Granath F, Sundström J, Näslund I, Marcus C, Ottosson J, Peltonen M, Carlsson LMS.

Lancet Diabetes Endocrinol. 2018 Mar;6(3):197-207. doi: 10.1016/S2213-8587(17)30437-0. Epub 2018 Jan 9.

8.

Comprehensive Proteomic Characterization of Ontogenic Changes in Hematopoietic Stem and Progenitor Cells.

Jassinskaja M, Johansson E, Kristiansen TA, Åkerstrand H, Sjöholm K, Hauri S, Malmström J, Yuan J, Hansson J.

Cell Rep. 2017 Dec 12;21(11):3285-3297. doi: 10.1016/j.celrep.2017.11.070.

9.

Lysyl oxidase and adipose tissue dysfunction.

Pastel E, Price E, Sjöholm K, McCulloch LJ, Rittig N, Liversedge N, Knight B, Møller N, Svensson PA, Kos K.

Metabolism. 2018 Jan;78:118-127. doi: 10.1016/j.metabol.2017.10.002. Epub 2017 Oct 17.

PMID:
29051043
10.

Bariatric surgery, glycaemic status, and microvascular complications - Authors' reply.

Carlsson LMS, Sjöholm K, Carlsson B, Peltonen M.

Lancet Diabetes Endocrinol. 2017 Jun;5(6):416-417. doi: 10.1016/S2213-8587(17)30145-6. No abstract available.

PMID:
28549504
11.

Macronutrient and alcohol intake is associated with intermuscular adipose tissue in a randomly selected group of younger and older men and women.

Sjöholm K, Gripeteg L, Larsson I.

Clin Nutr ESPEN. 2016 Jun;13:e46-e51. doi: 10.1016/j.clnesp.2016.04.002. Epub 2016 Apr 28.

PMID:
28531568
12.

Long-term incidence of female-specific cancer after bariatric surgery or usual care in the Swedish Obese Subjects Study.

Anveden Å, Taube M, Peltonen M, Jacobson P, Andersson-Assarsson JC, Sjöholm K, Svensson PA, Carlsson LMS.

Gynecol Oncol. 2017 May;145(2):224-229. doi: 10.1016/j.ygyno.2017.02.036. Epub 2017 Mar 1.

13.

Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study.

Carlsson LMS, Sjöholm K, Karlsson C, Jacobson P, Andersson-Assarsson JC, Svensson PA, Larsson I, Hjorth S, Neovius M, Taube M, Carlsson B, Peltonen M.

Lancet Diabetes Endocrinol. 2017 Apr;5(4):271-279. doi: 10.1016/S2213-8587(17)30061-X. Epub 2017 Feb 23.

14.

Targeted Proteomics and Absolute Protein Quantification for the Construction of a Stoichiometric Host-Pathogen Surface Density Model.

Sjöholm K, Kilsgård O, Teleman J, Happonen L, Malmström L, Malmström J.

Mol Cell Proteomics. 2017 Apr;16(4 suppl 1):S29-S41. doi: 10.1074/mcp.M116.063966. Epub 2017 Feb 9.

15.
16.

Weight Change-Adjusted Effects of Gastric Bypass Surgery on Glucose Metabolism: 2- and 10-Year Results From the Swedish Obese Subjects (SOS) Study.

Sjöholm K, Sjöström E, Carlsson LM, Peltonen M.

Diabetes Care. 2016 Apr;39(4):625-31. doi: 10.2337/dc15-1407. Epub 2015 Dec 17.

PMID:
26681719
17.

Development of Phage-Based Antibody Fragment Reagents for Affinity Enrichment of Bacterial Immunoglobulin G Binding Proteins.

Säll A, Sjöholm K, Waldemarson S, Happonen L, Karlsson C, Persson H, Malmström J.

J Proteome Res. 2015 Nov 6;14(11):4704-13. doi: 10.1021/acs.jproteome.5b00585. Epub 2015 Oct 27.

PMID:
26452057
18.

Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status: results from the Swedish Obese Subjects study.

Keating C, Neovius M, Sjöholm K, Peltonen M, Narbro K, Eriksson JK, Sjöström L, Carlsson LM.

Lancet Diabetes Endocrinol. 2015 Nov;3(11):855-65. doi: 10.1016/S2213-8587(15)00290-9. Epub 2015 Sep 17. Erratum in: Lancet Diabetes Endocrinol. 2015 Dec;3(12):e11.

19.

Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese Subjects (SOS) study.

Sjöholm K, Pajunen P, Jacobson P, Karason K, Sjöström CD, Torgerson J, Carlsson LM, Sjöström L, Peltonen M.

Diabetologia. 2015 Jul;58(7):1448-53. doi: 10.1007/s00125-015-3591-y. Epub 2015 Apr 30.

PMID:
25924987
20.

COL6A3 is regulated by leptin in human adipose tissue and reduced in obesity.

McCulloch LJ, Rawling TJ, Sjöholm K, Franck N, Dankel SN, Price EJ, Knight B, Liversedge NH, Mellgren G, Nystrom F, Carlsson LM, Kos K.

Endocrinology. 2015 Jan;156(1):134-46. doi: 10.1210/en.2014-1042.

PMID:
25337653
21.

Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.

Sjöström L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden Å, Bouchard C, Carlsson B, Karason K, Lönroth H, Näslund I, Sjöström E, Taube M, Wedel H, Svensson PA, Sjöholm K, Carlsson LM.

JAMA. 2014 Jun 11;311(22):2297-304. doi: 10.1001/jama.2014.5988.

PMID:
24915261
22.

The incidence of albuminuria after bariatric surgery and usual care in Swedish Obese Subjects (SOS): a prospective controlled intervention trial.

Carlsson LM, Romeo S, Jacobson P, Burza MA, Maglio C, Sjöholm K, Svensson PA, Haraldsson B, Peltonen M, Sjöström L.

Int J Obes (Lond). 2015 Jan;39(1):169-75. doi: 10.1038/ijo.2014.72. Epub 2014 May 6.

23.

Adipose tissue-derived human serum amyloid a does not affect atherosclerotic lesion area in hSAA1+/-/ApoE-/- mice.

Ahlin S, Olsson M, Wilhelmson AS, Skålén K, Borén J, Carlsson LM, Svensson PA, Sjöholm K.

PLoS One. 2014 Apr 21;9(4):e95468. doi: 10.1371/journal.pone.0095468. eCollection 2014.

24.

A comprehensive analysis of the Streptococcus pyogenes and human plasma protein interaction network.

Sjöholm K, Karlsson C, Linder A, Malmström J.

Mol Biosyst. 2014 Jul;10(7):1698-708. doi: 10.1039/c3mb70555b. Epub 2014 Feb 14.

PMID:
24525632
25.

No evidence for a role of adipose tissue-derived serum amyloid a in the development of insulin resistance or obesity-related inflammation in hSAA1(+/-) transgenic mice.

Ahlin S, Olsson M, Olsson B, Svensson PA, Sjöholm K.

PLoS One. 2013 Aug 15;8(8):e72204. doi: 10.1371/journal.pone.0072204. eCollection 2013.

26.

Endogenous Acute Phase Serum Amyloid A Lacks Pro-Inflammatory Activity, Contrasting the Two Recombinant Variants That Activate Human Neutrophils through Different Receptors.

Christenson K, Björkman L, Ahlin S, Olsson M, Sjöholm K, Karlsson A, Bylund J.

Front Immunol. 2013 Apr 22;4:92. doi: 10.3389/fimmu.2013.00092. eCollection 2013.

27.

Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study.

Burza MA, Romeo S, Kotronen A, Svensson PA, Sjöholm K, Torgerson JS, Lindroos AK, Sjöström L, Carlsson LM, Peltonen M.

PLoS One. 2013;8(3):e60495. doi: 10.1371/journal.pone.0060495. Epub 2013 Mar 26.

28.

Alcohol consumption and alcohol problems after bariatric surgery in the Swedish obese subjects study.

Svensson PA, Anveden Å, Romeo S, Peltonen M, Ahlin S, Burza MA, Carlsson B, Jacobson P, Lindroos AK, Lönroth H, Maglio C, Näslund I, Sjöholm K, Wedel H, Söderpalm B, Sjöström L, Carlsson LM.

Obesity (Silver Spring). 2013 Dec;21(12):2444-51. doi: 10.1002/oby.20397. Epub 2013 May 31.

29.

Macrophage gene expression in adipose tissue is associated with insulin sensitivity and serum lipid levels independent of obesity.

Ahlin S, Sjöholm K, Jacobson P, Andersson-Assarsson JC, Walley A, Tordjman J, Poitou C, Prifti E, Jansson PA, Borén J, Sjöström L, Froguel P, Bergman RN, Carlsson LM, Olsson B, Svensson PA.

Obesity (Silver Spring). 2013 Dec;21(12):E571-6. doi: 10.1002/oby.20443. Epub 2013 Jun 13.

30.

The IRS1 rs2943641 variant and risk of future cancer among morbidly obese individuals.

Maglio C, Ericson U, Burza MA, Mancina RM, Pirazzi C, Assarsson JA, Sjöholm K, Baroni MG, Svensson PA, Montalcini T, Pujia A, Sjöström L, Wiklund O, Carlsson LM, Borén J, Orho-Melander M, Romeo S.

J Clin Endocrinol Metab. 2013 Apr;98(4):E785-9. doi: 10.1210/jc.2012-2831. Epub 2013 Feb 15.

PMID:
23418314
31.

Evaluation of current eligibility criteria for bariatric surgery: diabetes prevention and risk factor changes in the Swedish obese subjects (SOS) study.

Sjöholm K, Anveden A, Peltonen M, Jacobson P, Romeo S, Svensson PA, Sjöström L, Carlsson LM.

Diabetes Care. 2013 May;36(5):1335-40. doi: 10.2337/dc12-1395. Epub 2013 Jan 28.

32.

Health care use during 20 years following bariatric surgery.

Neovius M, Narbro K, Keating C, Peltonen M, Sjöholm K, Agren G, Sjöström L, Carlsson L.

JAMA. 2012 Sep 19;308(11):1132-41.

PMID:
22990272
33.

Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects.

Carlsson LM, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, Jacobson P, Lönroth H, Maglio C, Näslund I, Pirazzi C, Romeo S, Sjöholm K, Sjöström E, Wedel H, Svensson PA, Sjöström L.

N Engl J Med. 2012 Aug 23;367(8):695-704. doi: 10.1056/NEJMoa1112082.

34.

Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes.

Romeo S, Maglio C, Burza MA, Pirazzi C, Sjöholm K, Jacobson P, Svensson PA, Peltonen M, Sjöström L, Carlsson LM.

Diabetes Care. 2012 Dec;35(12):2613-7. doi: 10.2337/dc12-0193. Epub 2012 Aug 1.

35.

PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals.

Burza MA, Pirazzi C, Maglio C, Sjöholm K, Mancina RM, Svensson PA, Jacobson P, Adiels M, Baroni MG, Borén J, Ginanni Corradini S, Montalcini T, Sjöström L, Carlsson LM, Romeo S.

Dig Liver Dis. 2012 Dec;44(12):1037-41. doi: 10.1016/j.dld.2012.05.006. Epub 2012 Jun 15.

PMID:
22704398
36.

ITIH-5 expression in human adipose tissue is increased in obesity.

Anveden Å, Sjöholm K, Jacobson P, Palsdottir V, Walley AJ, Froguel P, Al-Daghri N, McTernan PG, Mejhert N, Arner P, Sjöström L, Carlsson LM, Svensson PA.

Obesity (Silver Spring). 2012 Apr;20(4):708-14. doi: 10.1038/oby.2011.268. Epub 2011 Aug 18.

37.

Establishment of a transgenic mouse model specifically expressing human serum amyloid A in adipose tissue.

Olsson M, Ahlin S, Olsson B, Svensson PA, Ståhlman M, Borén J, Carlsson LM, Sjöholm K.

PLoS One. 2011;6(5):e19609. doi: 10.1371/journal.pone.0019609. Epub 2011 May 18.

38.

Gene expression in human brown adipose tissue.

Svensson PA, Jernås M, Sjöholm K, Hoffmann JM, Nilsson BE, Hansson M, Carlsson LM.

Int J Mol Med. 2011 Feb;27(2):227-32. doi: 10.3892/ijmm.2010.566. Epub 2010 Dec 1.

PMID:
21125211
39.

Expression of the selenoprotein S (SELS) gene in subcutaneous adipose tissue and SELS genotype are associated with metabolic risk factors.

Olsson M, Olsson B, Jacobson P, Thelle DS, Björkegren J, Walley A, Froguel P, Carlsson LM, Sjöholm K.

Metabolism. 2011 Jan;60(1):114-20. doi: 10.1016/j.metabol.2010.05.011.

40.

Changes in human adipose tissue gene expression during diet-induced weight loss.

Svensson PA, Gummesson A, Carlsson LMS, Sjöholm K.

World Rev Nutr Diet. 2010;101:103-114. doi: 10.1159/000314515. Epub 2010 Apr 30. Review. No abstract available.

41.

Activin B inhibits lipolysis in 3T3-L1 adipocytes.

Magnusson B, Svensson PA, Carlsson LM, Sjöholm K.

Biochem Biophys Res Commun. 2010 May 7;395(3):373-6. doi: 10.1016/j.bbrc.2010.04.022. Epub 2010 Apr 9.

PMID:
20382119
42.

Preliminary report: Zn-alpha2-glycoprotein genotype and serum levels are associated with serum lipids.

Olofsson LE, Olsson B, Lystig T, Jacobson P, Jernås M, Sjöholm K, Gummesson A, Sjöström L, Eriksson P, Hamsten A, Hale LP, Thelle DS, Carlsson B, Carlsson LM.

Metabolism. 2010 Sep;59(9):1316-8. doi: 10.1016/j.metabol.2009.12.006. Epub 2010 Jan 12.

PMID:
20070991
43.

Changes in human adipose tissue gene expression during diet-induced weight loss.

Svensson PA, Gummesson A, Carlsson LM, Sjöholm K.

J Nutrigenet Nutrigenomics. 2010;3(4-6):239-50. doi: 10.1159/000324360. Epub 2011 Apr 6. No abstract available.

PMID:
21474955
44.

Analytical techniques for characterizing enzymatic biofuel cells.

Moehlenbrock MJ, Arechederra RL, Sjöholm KH, Minteer SD.

Anal Chem. 2009 Dec 1;81(23):9538-45. doi: 10.1021/ac901243s.

PMID:
19888713
45.

Association of serum amyloid A levels with adipocyte size and serum levels of adipokines: differences between men and women.

Sjöholm K, Lundgren M, Olsson M, Eriksson JW.

Cytokine. 2009 Dec;48(3):260-6. doi: 10.1016/j.cyto.2009.08.005. Epub 2009 Sep 15.

PMID:
19758820
46.

Tenomodulin is highly expressed in adipose tissue, increased in obesity, and down-regulated during diet-induced weight loss.

Saiki A, Olsson M, Jernås M, Gummesson A, McTernan PG, Andersson J, Jacobson P, Sjöholm K, Olsson B, Yamamura S, Walley A, Froguel P, Carlsson B, Sjöström L, Svensson PA, Carlsson LM.

J Clin Endocrinol Metab. 2009 Oct;94(10):3987-94. doi: 10.1210/jc.2009-0292. Epub 2009 Jul 14.

PMID:
19602561
47.

ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease.

Carlsson LM, Jacobson P, Walley A, Froguel P, Sjöström L, Svensson PA, Sjöholm K.

Biochem Biophys Res Commun. 2009 May 1;382(2):309-14. doi: 10.1016/j.bbrc.2009.03.014. Epub 2009 Mar 9.

48.

Changes in adipose tissue gene expression and plasma levels of adipokines and acute-phase proteins in patients with critical illness.

Jernås M, Olsson B, Sjöholm K, Sjögren A, Rudemo M, Nellgård B, Carlsson LM, Sjöström CD.

Metabolism. 2009 Jan;58(1):102-8. doi: 10.1016/j.metabol.2008.08.012.

PMID:
19059537
49.

CCAAT/enhancer binding protein alpha (C/EBPalpha) in adipose tissue regulates genes in lipid and glucose metabolism and a genetic variation in C/EBPalpha is associated with serum levels of triglycerides.

Olofsson LE, Orho-Melander M, William-Olsson L, Sjöholm K, Sjöström L, Groop L, Carlsson B, Carlsson LM, Olsson B.

J Clin Endocrinol Metab. 2008 Dec;93(12):4880-6. doi: 10.1210/jc.2008-0574. Epub 2008 Sep 2.

PMID:
18765514
50.

Regulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissue.

Svensson PA, Gabrielsson BG, Jernås M, Gummesson A, Sjöholm K.

Cell Mol Biol Lett. 2008;13(4):599-613. doi: 10.2478/s11658-008-0025-6. Epub 2008 Jul 18.

Supplemental Content

Loading ...
Support Center